S&P 500
(0.04%) 5 471.40 points
Dow Jones
(0.08%) 39 145 points
Nasdaq
(0.36%) 17 781 points
Oil
(-0.01%) $80.82
Gas
(-3.66%) $2.66
Gold
(-0.80%) $2 312.20
Silver
(0.18%) $28.92
Platinum
(3.49%) $1 020.80
USD/EUR
(0.27%) $0.936
USD/NOK
(0.67%) $10.67
USD/GBP
(0.42%) $0.792
USD/RUB
(-0.27%) $87.25

Actualizaciones en tiempo real para Apexigen, Inc. [APGN]

Bolsa: NASDAQ Sector: Healthcare Industria: Biotechnology
Última actualización22 ago 2023 @ 15:59

8.48% $ 0.385

Live Chart Being Loaded With Signals

Commentary (22 ago 2023 @ 15:59):

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells...

Stats
Volumen de hoy 94 426
Volumen promedio 262 332
Capitalización de mercado 9.57M
EPS $-0.240 ( Q2 | 2023-08-10 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.225
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0390 (10.13%)
AADI -3.24%
ABCL 1.47%
ABCM 0.04%
ABEO -2.26%
ABIO -3.08%
ABOS 0.70%
ABSI 1.87%
ABUS -2.30%
ABVX -1.50%
ACAD -0.45%
ACER -17.95%
ACET -4.76%
ACGN 1.29%
ACHL 1.59%
ACHV -1.29%
ACIU -0.75%
ACLX 0.57%
ACRV -2.31%
ACST -2.90%
ACXP 2.30%
ADAG 4.64%
ADAP -4.03%
ADGI 0.87%
ADIL 0.24%
ADMA -2.00%
ADPT 0.44%
ADTX -2.38%
ADVM -3.47%
ADXN -1.60%
AEON -2.89%
AEZS -2.49%
AFMD -1.05%
AGEN -1.82%
AGIO -2.24%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 0.55%
AKRO -3.30%
AKTX 1.45%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC 0.69%
ALGS -0.74%
ALKS 0.33%
ALLK -9.36%
ALLO -5.42%
ALLR -0.53%
ALNA 3.16%
ALNY 2.60%
ALPN 0.02%
ALPX 0.00%
ALRN -1.82%
ALT -9.10%
ALVR 2.60%
ALXN 0.00%
ALXO -12.72%
ALZN 5.10%
AMRN -2.24%
AMTI -3.13%
ANAB 1.22%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX 0.88%
ANPC -3.15%
APGE 0.00%
APGN 8.48%
APGNW 30.65%
APLM -2.22%
APLS 0.45%
APLT -3.15%
APM 0.36%
APOP 0.38%
APRE 0.60%
APTO 5.98%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -4.93%
ARDS -14.23%
ARDX 0.33%
ARGX -0.93%
ARNA 0.00%
ARPO -0.90%
ARQT -0.94%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.09%
ARWR -1.12%
ASLN -3.83%
ASMB -5.81%
ASND -1.74%
ATAI -1.85%
ATHA 5.94%
ATHE 0.56%
ATHX -33.50%
ATNF 4.29%
ATOS 2.44%
ATRA -1.79%
ATXI -2.78%
ATXS -0.22%
AUPH -0.54%
AURA 2.79%
AUTL -1.87%
AVBP -1.89%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -3.79%
AVTX -1.25%
AVXL -4.19%
AXLA 0.00%
AXSM -1.08%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 2.50%
BCAB 5.88%
BCDA -2.23%
BCDAW -41.77%
BCEL 0.00%
BCLI 4.36%
BCRX 1.07%
BCTX 8.90%
BCTXW -16.32%
BCYC 0.85%
BDRX -4.62%
BDTX -1.49%
BEAM 1.20%
BFRA -2.91%
BGNE -2.60%
BIOR -5.96%
BIVI 3.65%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -0.78%
BLU 0.03%
BLUE 0.35%
BMEA -11.13%
BMRN 0.07%
BNOX 6.22%
BNTC -0.42%
BNTX -1.60%
BOLD -12.19%
BOLT -0.05%
BPMC -1.14%
BPTH 0.00%
BPTS -13.47%
BRNS 0.00%
BRTX -3.52%
BTAI 23.73%
BTTX 50.67%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 4.24%
CABA 1.17%
CADL -2.12%
CALA 0.00%
CALC -1.77%
CALT -1.59%
CAPR -1.72%
CARA 0.15%
CARM 13.90%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -4.61%
CCCC -5.84%
CCXI 0.00%
CDAK 0.00%
CDIO -2.18%
CDIOW 24.00%
CDMO -2.89%
CDMOP 0.04%
CDT -4.88%
CDTTW -39.60%
CDTX -1.31%
CDXC 1.02%
CDXS 7.93%
CELC -4.21%
CELU -1.98%
CELUW 11.80%
CERC -1.68%
CERE -1.42%
CERO -2.79%
CEROW -21.56%
CFRX -27.95%
CGEM -3.52%
CGEN -3.31%
CGON -1.46%
CGTX -3.43%
CHMA -6.00%
CHRS 1.90%
CINC 0.00%
CING -2.73%
CINGW 34.95%
CKPT -3.35%
CLBS -16.75%
CLDX -1.41%
CLGN 0.34%
CLLS -4.15%
CLNN 0.00%
CLNNW 0.00%
CLRB 6.30%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB -0.98%
CMND 2.06%
CMPI 0.00%
CMPX -1.42%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.48%
CNCE 0.00%
CNSP -35.93%
CNST 0.00%
CNTA -0.28%
CNTB 0.00%
CNTX -7.31%
COCP -2.00%
COEPW 32.45%
COGT -3.61%
CORT 2.86%
COYA 2.43%
CPRX -1.12%
CRBP -3.39%
CRBU -5.72%
CRDF -1.11%
CRGX -0.07%
CRIS -1.72%
CRNX -6.11%
CRSP 0.57%
CRTX 2.63%
CRVO -5.75%
CRVS 1.69%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -3.73%
CTNM -2.21%
CTXR 2.99%
CUE 6.60%
CVAC -5.65%
CVKD -2.85%
CWBR 2.80%
CYAD -12.96%
CYCC 9.09%
CYCCP 5.49%
CYCN -0.24%
CYT -2.27%
CYTK -2.09%
CYTO -1.82%
DARE 4.02%
DAWN -1.31%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 28.30%
DNLI -1.43%
DNTH -10.11%
DOMH 2.43%
DRMA -4.04%
DRMAW -1.25%
DRNA 0.00%
DRTS 3.45%
DRTSW 0.00%
DRUG 0.95%
DSGN -2.72%
DTIL 1.99%
DYAI 12.26%
EARS -1.77%
EDIT -2.41%
EDSA 3.49%
EFTR 6.39%
EFTRW -51.85%
EIGR -9.21%
ELAB -2.84%
ELDN 8.99%
ELEV -6.22%
ELOX -5.38%
ELTX -4.26%
ELVN -4.17%
ELYM 2.23%
ENGN -1.42%
ENGNW 0.00%
ENLV 2.90%
ENOB 1.79%
ENSC 3.23%
ENTA 0.08%
ENTO -2.42%
ENTX 1.60%
ENVB 2.24%
EPIX -2.36%
EPRX -1.15%
EPZM 0.00%
EQ 0.32%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.44%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -3.62%
ETON 1.83%
ETTX 0.00%
EVAX -2.14%
EVGN 4.76%
EVLO 0.00%
EWTX -0.35%
EXAI -1.13%
EXEL -0.02%
EYEG -0.69%
EYEN 1.53%
EYPT 0.42%
FATE -10.48%
FBIO 0.89%
FBIOP -0.37%
FBLG -15.40%
FBRX -0.02%
FDMT -3.41%
FENC -1.31%
FGEN -7.28%
FHTX 6.87%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -1.06%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.44%
FULC -3.51%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.28%
GANX -2.31%
GBIO -3.16%
GBT 0.01%
GDTC 0.50%
GERN -4.63%
GHRS -2.30%
GLMD -5.00%
GLPG -1.97%
GLSI 2.21%
GLTO -2.16%
GLUE -3.17%
GLYC -10.12%
GMAB -0.62%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -3.13%
GNLX 0.00%
GNPX 1.47%
GNTA 3.94%
GOSS -9.80%
GOVX 0.91%
GOVXW -49.04%
GPCR -7.35%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 1.44%
GRTX 5.14%
GTHX 0.23%
GUTS -4.39%
GXGXW 41.67%
GYRE -8.87%
HALO -1.20%
HARP 0.09%
HCWB -3.75%
HEPA -4.09%
HGEN -84.62%
HILS 5.66%
HLVX 0.15%
HOOK 2.33%
HOTH -3.51%
HOWL -1.50%
HRMY 1.94%
HRTX 4.26%
HSTO 0.00%
HUMA 0.71%
HUMAW -0.01%
IBRX -4.13%
ICCC -0.66%
ICPT 0.21%
ICU 19.18%
ICUCW 20.46%
ICVX -0.91%
IDRA -23.04%
IDYA -1.80%
IFRX -1.85%
IGMS -0.51%
IKNA 1.19%
IKT -0.35%
IMAB 2.33%
IMCR -3.02%
IMGN 0.02%
IMGO 0.00%
IMMP 3.23%
IMMX -7.76%
IMNM 0.35%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -0.67%
IMTXW 6.00%
IMUX 1.85%
IMV 0.00%
IMVT -4.80%
INAB -0.01%
INBX 0.73%
INCY -1.35%
INDP 7.80%
INFI -52.38%
INKT -0.01%
INM 1.49%
INMB 1.82%
INO -1.69%
INSM -1.49%
INTS -2.75%
INVA 0.59%
INZY 0.69%
IOBT -10.63%
IONS 0.96%
IOVA -3.31%
IPA -0.49%
IPHA 5.58%
IPSC -2.34%
IRON -1.79%
ISEE 0.38%
ITOS -1.68%
ITRM 1.67%
IVA 6.96%
IVVD -2.48%
JAGX 1.18%
JANX -3.69%
JAZZ -0.81%
JNCE 0.00%
JSPR -5.85%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -5.41%
KDNY 0.22%
KMPH -0.34%
KNSA -2.06%
KNTE -0.38%
KOD -6.52%
KPRX 0.00%
KPTI -5.48%
KRBP -10.00%
KRON 0.58%
KROS -1.06%
KRRO -8.11%
KRTX 0.03%
KRYS -0.52%
KTRA 8.59%
KTTA -6.79%
KTTAW 0.92%
KURA -0.29%
KYMR -2.99%
KYTX -3.69%
KZIA 5.29%
KZR -0.66%
LABP 0.57%
LBPH -1.53%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.98%
LENZ -5.20%
LEXX -1.54%
LEXXW -14.63%
LGND -0.50%
LGNDV 0.00%
LGVN -7.45%
LIAN -8.28%
LIFE 2.70%
LIPO -3.87%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.57%
LPCN -1.86%
LPTX -2.20%
LQDA -0.33%
LRMR -2.13%
LSTA -4.06%
LTRN 0.87%
LUMO -1.32%
LVTX -1.03%
LXEO -4.08%
LXRX -2.35%
LYEL -36.75%
LYRA 1.20%
MACK 0.10%
MBIO -8.92%
MBRX -1.72%
MCRB 2.47%
MDGL -1.30%
MDNA -13.16%
MDWD -0.14%
MDXG -2.58%
MEIP 1.40%
MESO -1.26%
MGNX -2.33%
MGTA -7.74%
MGTX -4.04%
MGX -4.02%
MIRM -0.78%
MIRO 0.59%
MIST 1.15%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX 0.40%
MLYS -7.48%
MNKD 0.29%
MNMD 0.07%
MNOV 2.11%
MNPR -8.52%
MOLN 2.46%
MOR 1.20%
MORF -3.24%
MREO -2.86%
MRKR 2.57%
MRNA -6.16%
MRNS -4.06%
MRSN -2.38%
MRTX -0.17%
MRUS 0.20%
MRVI -1.46%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -0.93%
MYMD 5.65%
NAMS 2.97%
NAMSW -0.21%
NAUT 1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 12.09%
NCNA 0.73%
NERV -0.63%
NEXI 1.84%
NGM -1.28%
NGNE -1.75%
NKGN 10.08%
NKGNW 8.00%
NKTR -4.21%
NKTX -4.24%
NLSP 5.28%
NLSPW 26.67%
NMRA -2.80%
NMTR -42.97%
NOVN -24.84%
NRBO 7.04%
NRIX -2.60%
NRSN -5.12%
NRSNW 0.00%
NRXP -3.72%
NRXPW 18.33%
NRXS 4.82%
NTBL 3.99%
NTEC -12.45%
NTHI 0.00%
NTLA -6.75%
NTRBW -31.07%
NUVL -1.83%
NVAX -2.16%
NVCT 2.82%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.92%
OABIW -10.06%
OBIO -2.92%
OBSV 0.00%
OCEA 0.00%
OCGN 2.12%
OCS -1.00%
OCUL 0.08%
OCUP 1.64%
ODT -4.27%
OKYO 1.51%
OLMA -5.20%
OMER -1.16%
OMGA 5.63%
ONCO 4.04%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY 1.48%
ONTX -0.47%
ONVO 1.31%
OPNT 0.00%
OPT 3.09%
ORGS 0.96%
ORIC -3.49%
ORMP 17.94%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.22%
OVID 1.43%
OYST 0.00%
PALI 1.30%
PASG -1.30%
PBLA -7.50%
PBM -3.48%
PBYI 1.01%
PCSA 0.00%
PCVX -0.22%
PDSB -3.01%
PEPG 1.38%
PGEN -2.40%
PHAR 1.51%
PHAS 0.00%
PHAT -1.40%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.32%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.65%
PLUR 7.39%
PMN 0.72%
PMVP -0.60%
PNT 0.16%
PPBT -6.38%
PRAX 4.83%
PRDS 0.93%
PRLD -2.37%
PROG -3.47%
PROK 0.22%
PRQR -0.66%
PRTA -2.70%
PRTC 0.49%
PRTG 7.02%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -10.46%
PSTX -0.97%
PTCT -0.37%
PTE -0.82%
PTGX -0.73%
PTIXW -48.41%
PULM 2.60%
PXMD 4.76%
PYPD 0.07%
PYXS 0.82%
QLGN -3.00%
QNCX 5.70%
QNRX -1.14%
QSI -11.97%
QSIAW -3.13%
QTTB -3.39%
QURE -0.90%
RAIN -1.63%
RANI 6.42%
RAPT -1.30%
RARE 1.45%
RCKT -8.81%
REGN 0.30%
RENB -3.42%
REPL -1.93%
RETA 0.02%
REUN -0.89%
REVB -2.79%
REVBU 3.46%
REVBW 5.00%
RGLS -6.78%
RGNX -5.84%
RIGL -3.29%
RLAY -3.86%
RLMD 0.35%
RLYB -1.34%
RNA 0.60%
RNAC -2.94%
RNAZ -1.92%
RNXT 0.89%
ROIV -2.17%
ROIVW 4.56%
RPHM -0.62%
RPRX 0.30%
RPTX -0.29%
RUBY 2.70%
RVLP -32.05%
RVMD -1.03%
RVMDW -30.00%
RVNC 0.21%
RVPH -1.98%
RVPHW 1.62%
RXDX 0.09%
RXRX -4.48%
RYTM -5.59%
RYZB 0.02%
RZLT 2.33%
SABS -1.37%
SABSW -11.81%
SAGE 1.19%
SANA -3.51%
SAVA -0.47%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -0.06%
SCPH 4.42%
SCPS 0.00%
SEEL -7.82%
SEER 0.65%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -0.87%
SGMT -2.66%
SGTX -2.56%
SIOX 22.63%
SLDB -8.62%
SLGL 2.91%
SLN -4.41%
SLNO -4.47%
SLRX 5.27%
SLS -1.71%
SMMT -1.12%
SNDX 0.97%
SNGX -4.91%
SNPX -4.39%
SONN 0.00%
SPPI -0.49%
SPRB 0.41%
SPRC -2.75%
SPRO 0.38%
SRNE -34.00%
SRPT -1.12%
SRRA 0.00%
SRRK -2.11%
SRZN -2.45%
STAB 0.00%
STOK -5.48%
STRO -3.13%
STSA 0.00%
STTK -1.69%
SURF -0.93%
SVRA -8.29%
SWTX -0.30%
SYBX -1.29%
SYRS -1.55%
TALS -0.73%
TARA -5.71%
TARS 0.81%
TBPH 0.48%
TCBP 2.48%
TCDA 0.00%
TCON 1.67%
TCRR 0.00%
TCRT 0.08%
TCRX -1.29%
TECH -0.08%
TENX 1.91%
TERN -8.81%
TFFP -5.33%
TGTX -4.40%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -4.60%
TNGX -3.78%
TNXP -6.25%
TNYA -5.06%
TPST 4.86%
TRDA -4.06%
TRVI 2.30%
TRVN 4.02%
TSHA -22.49%
TSVT -2.93%
TTNP -7.66%
TVTX 1.88%
TYRA -8.42%
UBX -2.84%
UNCY -3.84%
URGN -1.15%
UTHR 0.49%
VACC 11.36%
VALN -4.07%
VAXX 116.88%
VBIV 0.73%
VBLT -8.77%
VCEL 0.96%
VCNX 10.35%
VCYT -1.54%
VERA -4.50%
VERU 1.02%
VERV -3.06%
VIGL 4.84%
VINC 2.28%
VIR 0.89%
VIRI -1.73%
VIRX 3.15%
VKTX -1.36%
VLON -13.04%
VNDA -3.18%
VOR -2.41%
VRCA 0.07%
VRDN -4.62%
VRNA -0.47%
VRPX 0.38%
VRTX 0.40%
VSTM -1.33%
VTGN -1.81%
VTVT -2.97%
VTYX -2.09%
VXRT -4.38%
VYGR -0.26%
VYNE -4.62%
VYNT 7.78%
WINT 2.11%
WVE -6.50%
XBIO 1.03%
XBIT -1.88%
XCUR 3.55%
XENE -1.20%
XERS 2.62%
XFOR 4.71%
XLO 3.88%
XLRN 0.00%
XNCR 0.40%
XOMA -3.22%
XOMAO -0.16%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.72%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.83%
ZNTL -2.62%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-08-23 Zabrowksi Dan Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 146 383 Common Stock
2023-08-23 Wertheimer Samuel P Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 12 383 Warrants (right to buy)
2023-08-23 Wertheimer Samuel P Sell 1 845 Warrants (right to buy)
INSIDER POWER
-63.03
Last 97 transactions
Buy: 2 466 920 | Sell: 6 182 886

Volumen Correlación

Largo: 0.28 (neutral)
Corto: 0.00 (neutral)
Signal:(44.278) Neutral

Apexigen, Inc. Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Apexigen, Inc. Correlación - Moneda/Commodity

The country flag -0.03
( neutral )
The country flag 0.13
( neutral )
The country flag 0.00
( neutral )
The country flag -0.40
( neutral )
The country flag 0.00
( neutral )
The country flag 0.47
( neutral )

Apexigen, Inc. Finanzas

Annual 2022
Ingresos: $0
Beneficio Bruto: $0 (0.00 %)
EPS: $-1.590
FY 2022
Ingresos: $0
Beneficio Bruto: $0 (0.00 %)
EPS: $-1.590
FY 2021
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-0.931
FY 2020
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-3.36

Financial Reports:

No articles found.

Apexigen, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Apexigen, Inc.

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico

Total Execution Time: 3.5999307632446 seconds
Number of API calls: 3
Number of DB calls: 9